Login | Register

New Inhaler Drug Approved By FDA For Chronic COPD

The U.S. Food and Drug Administration has just announced the approval of a form of new long-term treatment for patients suffering from chronic obstructive pulmonary disease (COPD). The new treatment is an inhaler drug called Breo Ellipta (fluticasone furoate and vilanterol inhalation powder). It is also approved for the treatment of exacerbations in COPD patients...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *